Chengzhi Co., Ltd. (SHE:000990)
8.93
+0.27 (3.12%)
At close: Mar 6, 2026
Chengzhi Market Cap
Chengzhi has a market cap or net worth of 10.85 billion as of March 6, 2026. Its market cap has increased by 18.59% in one year.
Market Cap
10.85B
Enterprise Value
14.06B
Revenue
11.53B
Ranking
n/a
PE Ratio
93.85
Stock Price
8.93
Market Cap Chart
Since January 2, 2001, Chengzhi's market cap has increased from 4.51B to 10.85B, an increase of 140.82%. That is a compound annual growth rate of 3.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 10.85B | 12.75% |
| Dec 31, 2025 | 9.62B | 2.19% |
| Dec 31, 2024 | 9.42B | -5.60% |
| Dec 29, 2023 | 9.98B | -6.70% |
| Dec 30, 2022 | 10.69B | -44.37% |
| Dec 31, 2021 | 19.23B | 33.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 12.37B |
| Staidson (Beijing) BioPharmaceuticals | 11.90B |
| Chengdu Olymvax Biopharmaceuticals | 11.88B |
| Hualan Biological Vaccine | 11.34B |
| Beijing Hotgen Biotech | 11.28B |
| HitGen | 10.83B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.40B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.27B |